用户，您好！欢迎您进入重大新药创制—内分泌代谢平台！
请
登录
|
注册
NSTL重点领域信息门户
帮助中心
RSS
重点领域信息门户
重大新药创制—内分泌代谢
首页
资源分析
重点信息源
用户空间
高级检索
期刊浏览
您当前的位置：
首页
>
资源分析
来源机构
糖尿病护理(1,356)
DIABETOLOGIA?(834)
糖尿病(553)
t糖尿病(496)
糖尿病肥胖和代谢(412)
临床内分泌学与代谢杂志(275)
细胞代谢(126)
肥胖综述(85)
抗氧化剂和氧化还原信号(84)
当前脂质研究观点(65)
自由基生物与医学(63)
内分泌和代谢趋势(55)
骨和矿物质研究杂志(47)
心理神经内分泌学(36)
柳叶刀-糖尿病和内分泌(22)
自然内分泌学综述(20)
松果体研究杂志(16)
神经内分泌学前沿(14)
内分泌综述(9)
国际肥胖期刊和相关代谢紊乱杂志(2)
国家或组织
美国(1,722)
韩国(1,421)
德国(834)
英国(593)
机构类别
期刊(4,534)
国际重要组织(36)
资源性质
科技论文(4,550)
重要新闻(20)
监测目标对象
BMI(6)
抽取对象
diabetes(221)
Diabetes(217)
type 2 diabetes(194)
American Diabetes Association(188)
first(159)
the American Diabetes Association(142)
Diabetes Care(136)
type 1 diabetes(124)
glucose(122)
insulin resistance(122)
obesity(111)
BMI(110)
al(103)
Article Information(101)
CrossRef(101)
PubMed(100)
OpenUrl Abstract(98)
OpenUrl(96)
CI(92)
Duality of Interest(88)
Download(87)
cardiovascular(87)
obese(87)
cardiovascular disease(86)
?(85)
HbA1c(83)
diabetic(83)
Info & Metrics(78)
al ..(77)
secretion(75)
PDF(69)
CA(68)
hyperglycemia(67)
Fig(66)
liver(61)
tissue(61)
USA(60)
second(60)
Insulin(59)
Science ?(59)
JM(56)
Glucose(54)
K (54)
L (54)
Contributions(53)
First(53)
hepatic(52)
D (51)
hypertension(51)
pregnancy(51)
U.S.(50)
fat(49)
glucose tolerance(49)
hypoglycemia(49)
Acknowledgments(48)
N Engl J Med(47)
diabetes mellitus(47)
Next Back(46)
OpenUrl CrossRef(46)
blood(46)
islet(45)
β-cell(45)
MA(43)
genetic(43)
ME(42)
Metab(42)
Type 2 Diabetes(42)
metformin(42)
overweight(42)
skeletal muscle(42)
Second(41)
weight loss(41)
DOI(39)
View(39)
m2(39)
muscle(39)
HDL(38)
Next (38)
RR(38)
vascular(38)
Germany(37)
Lancet Diabetes Endocrinol(37)
hyperglycaemia(37)
type 2 diabetes mellitus(37)
II(36)
Novo Nordisk(36)
UK(36)
prediabetes(36)
Fig(35)
T2D(35)
Type 1 Diabetes(35)
renal(35)
National Institutes of Health(34)
RNA(34)
weight gain(34)
C-peptide(33)
METHODS(33)
beta cell(33)
infarction(33)
BP(32)
Digestive(32)
ESM Fig(32)
JM (32)
OpenUrl FREE(32)
impaired glucose tolerance(32)
stroke(32)
Chen(31)
Table 1(31)
adipocytes(31)
dyslipidemia(31)
pancreas(31)
AL (30)
Australia(30)
Clinical(30)
European(30)
RA(30)
type 1 diabetes mellitus(30)
ANOVA(29)
Jun(29)
MD(29)
Physiology(29)
brain(29)
American(28)
CVD(28)
JA(28)
JL(28)
Obesity(28)
third(28)
Clin Endocrinol(27)
DR(27)
ESM(27)
J Clin Invest(27)
SD(27)
U.K.(27)
cholesterol(27)
glucagon(27)
glucose intolerance(27)
EJ(26)
G (26)
JAMA(26)
NJ(26)
Student(26)
T1D(26)
heart failure(26)
microvascular(26)
China(25)
LA(25)
MJ (25)
PLoS One(25)
Pregnancy(25)
San Diego(25)
Sanofi(25)
apoptosis(25)
blood pressure(25)
gut(25)
ESM Table(24)
H (24)
JC(24)
JS(24)
Japan(24)
MJ(24)
MO(24)
Nat Rev(24)
Plasma(24)
Third(24)
coronary artery disease(24)
gestational diabetes mellitus(24)
retinopathy(24)
ACE(23)
ESM Table 2(23)
GDM(23)
GLP-1(23)
NC(23)
PA(23)
RA (23)
RJ(23)
RS(23)
SJ(23)
Sci(23)
US(23)
disease(23)
endocrine(23)
kidney(23)
pancreatic islets(23)
’s(23)
ELISA(22)
Hypertension(22)
JE (22)
NIH(22)
Research Design(22)
Summary(22)
adipocyte(22)
cardiac(22)
chronic kidney disease(22)
dapagliflozin(22)
insulin therapy(22)
kidney disease(22)
±(22)
AJ(21)
BMJ(21)
Boehringer Ingelheim(21)
Canada(21)
Denmark(21)
Eli Lilly(21)
JDRF(21)
KM (21)
L(21)
Lee(21)
Methods.(21)
OGTT(21)
Sweden(21)
X (21)
beta cells(21)
diabetes care(21)
leptin(21)
receptor(21)
total cholesterol(21)
1C(20)
AUC(20)
Am J Physiol(20)
AstraZeneca(20)
Diabetologia(20)
ESM Table 1(20)
JF(20)
Kim(20)
Next Back(20)
Type 1 diabetes(20)
adipose(20)
atherosclerosis(20)
cancer(20)
hypoglycaemia(20)
ketoacidosis(20)
the National Institutes of Health(20)
AR(19)
Biol Chem(19)
CJ (19)
Cambridge(19)
Clin(19)
D(19)
DK(19)
DS(19)
Diabetes Care 2014(19)
HOMA-IR(19)
JR (19)
K(19)
OpenUrl View Abstract(19)
RJ (19)
SA(19)
SJ (19)
Supplementary Fig(19)
Table 2(19)
albumin(19)
diabetic retinopathy(19)
endothelial(19)
insulin-resistant(19)
interplay(19)
subcutaneous(19)
β-cells(19)
Abbott(18)
Anderson(18)
ClinicalTrials.gov(18)
F(18)
IN(18)
JP (18)
Jul(18)
KB(18)
LM(18)
Lachin(18)
MM(18)
Mol(18)
SAS(18)
SE(18)
SS(18)
Supplementary Data(18)
Type 2 diabetes(18)
absorption(18)
autoimmune(18)
autoimmunity(18)
hepatocytes(18)
infection(18)
the United States(18)
white adipose tissue(18)
ADA(17)
Asian(17)
California(17)
Dapagliflozin(17)
Davis(17)
Diet(17)
F (17)
France(17)
HA(17)
JW(17)
Merck(17)
Merck Sharp & Dohme(17)
Netherlands(17)
OpenUrl Abstract / FREE(17)
PA (17)
RM (17)
Roche(17)
SK (17)
SM (17)
TX(17)
United States(17)
WA(17)
depression(17)
mice(17)
the Declaration of Helsinki(17)
the National Institute of Diabetes(17)
Akt(16)
American Heart Association(16)
CGM(16)
Cox(16)
Diabetes Mellitus(16)
Europe(16)
HLA(16)
Insulin resistance(16)
NASH(16)
OR(16)
OpenUrl FREE (16)
SR(16)
T cells(16)
View Abstract(16)
coronary heart disease(16)
heart(16)
macrophages(16)
murine(16)
plasma(16)
secondary(16)
BM(15)
Blood Institute(15)
Briefly(15)
CV(15)
Cardiovascular(15)
DCCT(15)
Danish(15)
EDIC(15)
EW(15)
GA(15)
GWAS(15)
JB (15)
JS (15)
Jr (15)
Korea(15)
LM (15)
Lung(15)
NA(15)
Nat Med(15)
Novartis(15)
OpenUrl PubMed(15)
S (15)
SAS Institute(15)
WC(15)
Xu(15)
Youth(15)
Zhou(15)
dementia(15)
end-stage renal disease(15)
endothelial cells(15)
gestational diabetes(15)
http://www.diabetesjournals.org/content/license.View Abstract(15)
macrophage(15)
nephropathy(15)
renal disease(15)
χ2(15)
%(14)
AA(14)
AD(14)
AH (14)
AP(14)
Amgen(14)
Atherosclerosis(14)
C57BL/6(14)
College Station(14)
Colorado(14)
Comparison(14)
Complications(14)
Diabet Med(14)
Fasting(14)
GraphPad Prism(14)
HFD(14)
IBM(14)
IR(14)
India(14)
Janssen(14)
L.(14)
LS(14)
London(14)
MI(14)
NM(14)
NY(14)
Nathan(14)
Pfizer(14)
Physiol(14)
R01(14)
San Francisco(14)
Supplementary Table 1(14)
Swedish(14)
brown adipose tissue(14)
coronary(14)
fibrosis(14)
inflammation(14)
kidneys(14)
nonalcoholic steatohepatitis(14)
retinal(14)
type 2 diabetic(14)
?±(13)
AJ (13)
AMPK(13)
C57BL/6J(13)
CJ(13)
Canagliflozin(13)
Cary(13)
Clin Pract(13)
Congress(13)
DA (13)
Diabetes Control(13)
ES(13)
HA (13)
HbA(13)
Hispanic(13)
IL(13)
J (13)
J Med(13)
Liver(13)
Mathieu(13)
N (13)
NOD(13)
Nat Commun(13)
Next(13)
PJ (13)
Pearson(13)
RC(13)
RL(13)
RM(13)
Roche Diagnostics(13)
SC (13)
SGLT(13)
Sigma-Aldrich(13)
Stata(13)
T2DM(13)
Thermo Fisher Scientific(13)
Type 1(13)
VA(13)
al.(13)
antihypertensive(13)
capillary(13)
cardiovascular diseases(13)
coronary artery(13)
diabetic kidney disease(13)
diabetic nephropathy(13)
insulin-dependent diabetes mellitus(13)
metabolic disorders(13)
mouse(13)
the Diabetes Prevention Program(13)
2(12)
A1C(12)
ANCOVA(12)
African(12)
Boston(12)
CP(12)
Cary, NC(12)
Clin Nutr(12)
DEPICT-1(12)
DG(12)
Finland(12)
Fourth(12)
GAD(12)
Islet(12)
J(12)
JH (12)
JP(12)
Johnson(12)
KL(12)
LA (12)
LS (12)
MACE(12)
ME (12)
ML(12)
ML (12)
Max Bingham(12)
Metformin(12)
NAFLD(12)
ND(12)
Obese(12)
PM (12)
Qiagen(12)
SEM(12)
Scientific Sessions(12)
Statistical Analysis(12)
T cell(12)
TA(12)
TA (12)
Time(12)
Total cholesterol(12)
Web of Science(12)
Wu(12)
acute coronary syndrome(12)
cell death(12)
cognitive impairment(12)
critical role(12)
监测主题
blood glucose(65)
blood sugar(2)
抽取主题
increased risk(115)
insulin resistance(72)
body weight(61)
glucose tolerance(55)
glycemic control(54)
high risk(52)
insulin sensitivity(52)
high-fat diet(51)
weight loss(51)
adipose tissue(48)
cardiovascular disease(47)
skeletal muscle(46)
glucose metabolism(41)
glycaemic control(41)
glucose intolerance(37)
glucose homeostasis(35)
plasma glucose(35)
insulin secretion(33)
oxidative stress(31)
metabolic syndrome(30)
physical activity(30)
lipid metabolism(28)
electronic supplementary material(27)
cardiovascular risk(26)
significant increase(26)
weight gain(26)
mouse model(24)
systolic blood pressure(23)
bariatric surgery(22)
impaired glucose tolerance(22)
myocardial infarction(22)
significant reduction(22)
protein expression(21)
risk factor(21)
significant difference(21)
blood pressure(20)
improved glucose tolerance(20)
increased expression(20)
waist circumference(20)
beneficial effect(19)
fatty acid(19)
gene expression(19)
reactive oxygen species(19)
significant effect(19)
all-cause mortality(18)
body composition(18)
family history(17)
sensitivity analysis(17)
significant decrease(17)
transcription factor(17)
clinical care(16)
fat mass(16)
intensive lifestyle intervention(16)
mitochondrial function(16)
energy expenditure(15)
fasting glucose(15)
glucose control(15)
hepatic steatosis(15)
informed consent(15)
lower risk(15)
mitochondrial dysfunction(15)
reduced risk(15)
statistical significance(15)
clinical research(14)
low risk(14)
normal glucose tolerance(14)
statistical analysis(14)
diet-induced obesity(13)
increasing evidence(13)
metabolic control(13)
natural history(13)
clinical trial(12)
data collection(12)
diabetic ketoacidosis(12)
energy homeostasis(12)
glucose uptake(12)
health care(12)
heart failure(12)
high glucose(12)
high prevalence(12)
improved insulin sensitivity(12)
positive association(12)
postprandial glucose(12)
protein kinase(12)
significant improvement(12)
coronary heart disease(11)
disease progression(11)
endoplasmic reticulum(11)
energy metabolism(11)
fatty liver disease(11)
growing body(11)
hepatic glucose production(11)
independent risk factor(11)
lipid oxidation(11)
metabolic health(11)
metabolic regulation(11)
precision medicine(11)
protective effect(11)
relative contribution(11)
supporting information(11)
therapeutic potential(11)
article content(10)
cell death(10)
chronic kidney disease(10)
continuous glucose monitoring(10)
disease process(10)
endogenous glucose production(10)
endothelial function(10)
energy intake(10)
fatty acid oxidation(10)
fetal growth(10)
glucagon-like peptide-1(10)
glucose cotransporter(10)
growth hormone(10)
intensive treatment(10)
lifestyle modification(10)
marked increase(10)
novo lipogenesis(10)
potential target(10)
randomized controlled trial(10)
recent-onset type(10)
renal disease(10)
statistical power(10)
written informed consent(10)
basal insulin(9)
blood glucose concentration(9)
body fat(9)
cardiovascular mortality(9)
causal relationship(9)
chronic inflammation(9)
cognitive function(9)
cumulative incidence(9)
data analysis(9)
data show(9)
direct comparison(9)
food intake(9)
genetic risk(9)
glucose infusion rate(9)
gold standard(9)
increased incidence(9)
islet function(9)
lifestyle intervention(9)
lipid profile(9)
logistic regression(9)
mass spectrometry(9)
metabolic phenotype(9)
negative regulator(9)
nitric oxide(9)
oral glucose tolerance(9)
peroxisome proliferator(9)
position statement(9)
potential mechanism(9)
receptor agonist(9)
significant association(9)
significant change(9)
significant interaction(9)
statistically significant difference(9)
blood flow(8)
clear evidence(8)
clinical data(8)
differential expression(8)
disease duration(8)
energy balance(8)
excess risk(8)
fasting plasma glucose(8)
fat distribution(8)
gastrointestinal tract(8)
gestational weight gain(8)
glucagon-like peptide(8)
glucose disposal(8)
growing evidence(8)
healthy control(8)
high rate(8)
human type(8)
impaired fasting glucose(8)
incident type(8)
individual patient(8)
insulin action(8)
key component(8)
key regulator(8)
leading cause(8)
lipid accumulation(8)
liquid nitrogen(8)
mammalian target(8)
marked reduction(8)
metabolic disease(8)
metabolic risk(8)
normal glucose(8)
peripheral blood(8)
potential impact(8)
progressive loss(8)
rapid increase(8)
rat model(8)
risk stratification(8)
subcutaneous adipose tissue(8)
vascular endothelial growth factor(8)
adipocyte differentiation(7)
alcohol consumption(7)
birth cohort(7)
cardiovascular death(7)
cardiovascular safety(7)
cell proliferation(7)
cell surface(7)
cell survival(7)
chronic disease(7)
convincing evidence(7)
diastolic blood pressure(7)
dietary intake(7)
direct effect(7)
effective treatment(7)
energy restriction(7)
ex vivo(7)
fatty liver(7)
genetic background(7)
genetic variant(7)
glucose production(7)
glycemic variability(7)
growth factor(7)
heart rate(7)
hepatic gluconeogenesis(7)
high fat diet(7)
increased plasma(7)
increased susceptibility(7)
increased type(7)
inflammatory response(7)
intensive glucose(7)
intensive therapy(7)
islet transplantation(7)
later life(7)
life expectancy(7)
linear regression(7)
long-term treatment(7)
longer duration(7)
mean ±(7)
median follow-up(7)
medical history(7)
microvascular disease(7)
mitochondrial activity(7)
new-onset type(7)
next-generation sequencing(7)
nonalcoholic fatty liver disease(7)
novel approach(7)
novel therapeutic target(7)
oxygen consumption(7)
peripheral insulin sensitivity(7)
positive correlation(7)
reduced expression(7)
similar pattern(7)
solid line(7)
subgroup analysis(7)
systemic inflammation(7)
therapeutic strategy(7)
therapeutic target(7)
visceral adipose tissue(7)
weight change(7)
youth-onset type(7)
acute effect(6)
adipose tissue inflammation(6)
blood glucose control(6)
cardiometabolic risk(6)
cardiovascular disease risk(6)
cell type(6)
childhood obesity(6)
clinical benefit(6)
compensatory increase(6)
comprehensive assessment(6)
continuous glucose(6)
correlation coefficient(6)
cytokine production(6)
data implicate(6)
detrimental effect(6)
diabetic nephropathy(6)
diabetic retinopathy(6)
different cell(6)
disease onset(6)
double-blind trial(6)
elevated risk(6)
emerging evidence(6)
endothelial dysfunction(6)
experimental evidence(6)
first-line treatment(6)
flow cytometry(6)
genetic predisposition(6)
genetic risk score(6)
glucose variability(6)
glucose-lowering medication(6)
high expression(6)
human islet(6)
human skeletal muscle(6)
incidence rate(6)
increased adiposity(6)
insulin-stimulated glucose uptake(6)
intensive glycemic control(6)
islet autoimmunity(6)
key player(6)
kidney disease(6)
lactic acidosis(6)
life course(6)
lipid synthesis(6)
long-standing type(6)
long-term follow-up(6)
long-term safety data(6)
longitudinal data(6)
low-grade inflammation(6)
maternal obesity(6)
mean value(6)
metabolic flexibility(6)
metabolic function(6)
metabolic homeostasis(6)
metabolic response(6)
metformin therapy(6)
mitochondrial biogenesis(6)
molecular mechanism(6)
neutral effect(6)
novel mechanism(6)
nuclear factor(6)
observational data(6)
original research(6)
paraventricular nucleus(6)
patient care(6)
peripheral neuropathy(6)
placebo-controlled trial(6)
plasma membrane(6)
positive effect(6)
potential bias(6)
potential therapeutic target(6)
predictive value(6)
proliferator-activated receptor(6)
prospective cohort(6)
prospective design(6)
randomised clinical trial(6)
rate-limiting enzyme(6)
regulatory approval(6)
related content(6)
relative importance(6)
renal failure(6)
renal function(6)
residual confounding(6)
selection bias(6)
serum cholesterol(6)
serum glucose(6)
severe hypoglycaemia(6)
severe insulin resistance(6)
shorter duration(6)
survival analysis(6)
unique opportunity(6)
weight reduction(6)
western blot(6)
western blotting(6)
2-h glucose(5)
advanced glycation end(5)
animal model(5)
autoimmune destruction(5)
baseline data(5)
beneficial metabolic(5)
blood pressure control(5)
blot analysis(5)
body weight loss(5)
bone marrow(5)
caloric restriction(5)
cardiorespiratory fitness(5)
cardiovascular outcome(5)
carotid intima-media thickness(5)
cell function(5)
cell viability(5)
chronic exposure(5)
chronic treatment(5)
clinical information(5)
cognitive performance(5)
collaborative meta-analysis(5)
combination therapy(5)
compelling evidence(5)
concomitant increase(5)
consummatory lordosis quotient(5)
coronary artery disease(5)
dark cycle(5)
design 48h(5)
ectopic expression(5)
evidence-based treatment(5)
exploratory analysis(5)
fat accumulation(5)
fat storage(5)
fatty acid synthesis(5)
female sexual desire(5)
gastric inhibitory(5)
gene expression profile(5)
genetic information(5)
genetic variation(5)
glomerular filtration rate(5)
glucose concentration(5)
glucose monitoring(5)
glucose transporter(5)
glucose utilisation(5)
glucose-lowering treatment(5)
glycogen content(5)
gradual increase(5)
gut microbiome(5)
healthy diet(5)
healthy eating(5)
hepatic glucose output(5)
high proportion(5)
hospital admission(5)
human obesity(5)
hypoactive sexual desire disorder(5)
increased energy expenditure(5)
increased mortality(5)
increased physical activity(5)
increased serum(5)
increasing prevalence(5)
incremental area(5)
insulin production(5)
insulin receptor(5)
insulin release(5)
insulin tolerance(5)
insulinotropic polypeptide(5)
inverse relationship(5)
key enzyme(5)
key mediator(5)
key question(5)
latent autoimmune(5)
liquid chromatography(5)
liver steatosis(5)
long-term safety(5)
low expression(5)
lower blood glucose(5)
lower rate(5)
magnetic resonance(5)
maternal glucose(5)
maternal nutrition(5)
mechanistic insight(5)
mechanistic target(5)
medical care(5)
medical treatment(5)
mental health(5)
mitochondrial content(5)
mitochondrial respiration(5)
mitogen-activated protein(5)
modest reduction(5)
mortality rate(5)
negative effect(5)
negative impact(5)
nonalcoholic steatohepatitis(5)
novel strategy(5)
oxidative damage(5)
oxidative metabolism(5)
oxidative phosphorylation(5)
pancreatic progenitor(5)
paradigm shift(5)
pharmacological therapy(5)
potential risk(5)
promoter region(5)
prospective data(5)
protein response(5)
protein synthesis(5)
randomized placebo-controlled(5)
receptor substrate(5)
regression analysis(5)
response relationship(5)
rheumatoid arthritis(5)
sex difference(5)
significant impact(5)
small increase(5)
socioeconomic status(5)
study population(5)
subsequent development(5)
substantial reduction(5)
systematic evaluation(5)
testosterone propionate(5)
tight control(5)
underlying mechanism(5)
western blot analysis(5)
white adipose tissue(5)
10-year follow-up(4)
abdominal obesity(4)
abstract form(4)
ad libitum(4)
ad libitum access(4)
add-on therapy(4)
adoptive transfer(4)
arcuate nucleus(4)
aromatic amino(4)
arterial stiffness(4)
aspartic acid(4)
big data(4)
biliopancreatic diversion(4)
brain structure(4)
capillary density(4)
cardiovascular health(4)
cardiovascular protection(4)
causal association(4)
cell biology(4)
cellular stress(4)
cerebrovascular disease(4)
chronic autoimmune disease(4)
clinical diagnosis(4)
clinical experience(4)
clinical impact(4)
clinical importance(4)
clinical management(4)
clinical relevance(4)
发布时间
2016(1,139)
2015(868)
2019(844)
2018(667)
2014(571)
2017(478)
2002(1)
2009(1)
2010(1)
文档类型
PDF(56)
DOC(X)(0)
PPT(X)(0)
XLS(X)(0)
TEXT(0)
语言种类
英语(4563)
德语(1)
法语(2)
日语(0)
汉语(0)
其他(4)
发布时间跨度
从
到
